mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.01 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.01 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
blebbistatin |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
0.01 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.01 |
mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.01 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.01 |